List of Tables
Table 1. Global Multiple Myeloma Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Radiation
Table 4. Key Players of Stem Cell Transplant
Table 5. Key Players of Other Supportive Treatments
Table 6. Global Multiple Myeloma Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Multiple Myeloma Therapeutics Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 8. Global Multiple Myeloma Therapeutics Revenue by Region (2017-2022) & (US$ Million)
Table 9. Global Multiple Myeloma Therapeutics Revenue Market Share by Region (2017-2022)
Table 10. Global Multiple Myeloma Therapeutics Revenue by Players (2017-2022) & (US$ Million)
Table 11. Global Multiple Myeloma Therapeutics Market Share by Players (2017-2022)
Table 12. Global Top Multiple Myeloma Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiple Myeloma Therapeutics as of 2021)
Table 13. Ranking of Global Top Multiple Myeloma Therapeutics Companies by Revenue (US$ Million) in 2021
Table 14. Global 5 Largest Players Market Share by Multiple Myeloma Therapeutics Revenue (CR5 and HHI) & (2017-2022)
Table 15. Key Players Headquarters and Area Served
Table 16. Key Players Multiple Myeloma Therapeutics Product Solution and Service
Table 17. Date of Key Manufacturers Enter into Multiple Myeloma Therapeutics Market
Table 18. Mergers & Acquisitions, Expansion Plans
Table 19. Global Multiple Myeloma Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 20. Global Multiple Myeloma Therapeutics Revenue Market Share by Type (2017-2022)
Table 21. Global Multiple Myeloma Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 22. Global Multiple Myeloma Therapeutics Revenue Market Share by Type (2023-2028)
Table 23. Global Multiple Myeloma Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 24. Global Multiple Myeloma Therapeutics Revenue Market Share by Application (2017-2022)
Table 25. Global Multiple Myeloma Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 26. Global Multiple Myeloma Therapeutics Revenue Market Share by Application (2023-2028)
Table 27. North America Multiple Myeloma Therapeutics Revenue by Company (2020-2022) & (US$ Million)
Table 28. North America Multiple Myeloma Therapeutics Revenue by Type (2017-2022) & (US$ Million)
Table 29. North America Multiple Myeloma Therapeutics Revenue by Type (2023-2028) & (US$ Million)
Table 30. North America Multiple Myeloma Therapeutics Revenue by Application (2017-2022) & (US$ Million)
Table 31. North America Multiple Myeloma Therapeutics Revenue by Application (2023-2028) & (US$ Million)
Table 32. North America Multiple Myeloma Therapeutics Revenue by Country (2017-2022) & (US$ Million)
Table 33. North America Multiple Myeloma Therapeutics Revenue by Country (2023-2028) & (US$ Million)
Table 34. Europe Multiple Myeloma Therapeutics Revenue by Company (2020-2022) & (US$ Million)
Table 35. Europe Multiple Myeloma Therapeutics Revenue by Type (2017-2022) & (US$ Million)
Table 36. Europe Multiple Myeloma Therapeutics Revenue by Type (2023-2028) & (US$ Million)
Table 37. Europe Multiple Myeloma Therapeutics Revenue by Application (2017-2022) & (US$ Million)
Table 38. Europe Multiple Myeloma Therapeutics Revenue by Application (2023-2028) & (US$ Million)
Table 39. Europe Multiple Myeloma Therapeutics Revenue by Country (2017-2022) & (US$ Million)
Table 40. Europe Multiple Myeloma Therapeutics Revenue by Country (2023-2028) & (US$ Million)
Table 41. Asia Pacific Multiple Myeloma Therapeutics Revenue by Company (2020-2022) & (US$ Million)
Table 42. Asia Pacific Multiple Myeloma Therapeutics Revenue by Type (2017-2022) & (US$ Million)
Table 43. Asia Pacific Multiple Myeloma Therapeutics Revenue by Type (2023-2028) & (US$ Million)
Table 44. Asia Pacific Multiple Myeloma Therapeutics Revenue by Application (2017-2022) & (US$ Million)
Table 45. Asia Pacific Multiple Myeloma Therapeutics Revenue by Application (2023-2028) & (US$ Million)
Table 46. Asia Pacific Multiple Myeloma Therapeutics Revenue by Region (2017-2022) & (US$ Million)
Table 47. Asia Pacific Multiple Myeloma Therapeutics Revenue by Region (2023-2028) & (US$ Million)
Table 48. Latin America Multiple Myeloma Therapeutics Revenue by Company (2020-2022) & (US$ Million)
Table 49. Latin America Multiple Myeloma Therapeutics Revenue by Type (2017-2022) & (US$ Million)
Table 50. Latin America Multiple Myeloma Therapeutics Revenue by Type (2023-2028) & (US$ Million)
Table 51. Latin America Multiple Myeloma Therapeutics Revenue by Application (2017-2022) & (US$ Million)
Table 52. Latin America Multiple Myeloma Therapeutics Revenue by Application (2023-2028) & (US$ Million)
Table 53. Latin America Multiple Myeloma Therapeutics Revenue by Country (2017-2022) & (US$ Million)
Table 54. Latin America Multiple Myeloma Therapeutics Revenue by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Multiple Myeloma Therapeutics Revenue by Company (2020-2022) & (US$ Million)
Table 56. Middle East and Africa Multiple Myeloma Therapeutics Revenue by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Multiple Myeloma Therapeutics Revenue by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Multiple Myeloma Therapeutics Revenue by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Multiple Myeloma Therapeutics Revenue by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Multiple Myeloma Therapeutics Revenue by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Multiple Myeloma Therapeutics Revenue by Country (2023-2028) & (US$ Million)
Table 62. Janssen Biotech, Inc. Company Details
Table 63. Janssen Biotech, Inc. Business Overview
Table 64. Janssen Biotech, Inc. Multiple Myeloma Therapeutics Product and Services
Table 65. Janssen Biotech, Inc. Multiple Myeloma Therapeutics Revenue in Multiple Myeloma Therapeutics Business (2017-2022) & (US$ Million)
Table 66. Janssen Biotech, Inc. Multiple Myeloma Therapeutics SWOT Analysis
Table 67. Janssen Biotech, Inc. Recent Developments
Table 68. Bristol-Myers Squibb Company Details
Table 69. Bristol-Myers Squibb Business Overview
Table 70. Bristol-Myers Squibb Multiple Myeloma Therapeutics Product and Services
Table 71. Bristol-Myers Squibb Multiple Myeloma Therapeutics Revenue in Multiple Myeloma Therapeutics Business (2017-2022) & (US$ Million)
Table 72. Bristol-Myers Squibb Multiple Myeloma Therapeutics SWOT Analysis
Table 73. Bristol-Myers Squibb Recent Developments
Table 74. Novartis AG Company Details
Table 75. Novartis AG Business Overview
Table 76. Novartis AG Multiple Myeloma Therapeutics Product and Services
Table 77. Novartis AG Multiple Myeloma Therapeutics Revenue in Multiple Myeloma Therapeutics Business (2017-2022) & (US$ Million)
Table 78. Novartis AG Multiple Myeloma Therapeutics SWOT Analysis
Table 79. Novartis AG Recent Developments
Table 80. Bristol-Myers Squibb Company Company Details
Table 81. Bristol-Myers Squibb Company Business Overview
Table 82. Bristol-Myers Squibb Company Multiple Myeloma Therapeutics Product and Services
Table 83. Bristol-Myers Squibb Company Multiple Myeloma Therapeutics Revenue in Multiple Myeloma Therapeutics Business (2017-2022) & (US$ Million)
Table 84. Bristol-Myers Squibb Company Multiple Myeloma Therapeutics SWOT Analysis
Table 85. Bristol-Myers Squibb Company Recent Developments
Table 86. Millennium Pharmaceuticals Company Details
Table 87. Millennium Pharmaceuticals Business Overview
Table 88. Millennium Pharmaceuticals Multiple Myeloma Therapeutics Product and Services
Table 89. Millennium Pharmaceuticals Multiple Myeloma Therapeutics Revenue in Multiple Myeloma Therapeutics Business (2017-2022) & (US$ Million)
Table 90. Millennium Pharmaceuticals Multiple Myeloma Therapeutics SWOT Analysis
Table 91. Millennium Pharmaceuticals Recent Developments
Table 92. Celgene Corporation Company Details
Table 93. Celgene Corporation Business Overview
Table 94. Celgene Corporation Multiple Myeloma Therapeutics Product and Services
Table 95. Celgene Corporation Multiple Myeloma Therapeutics Revenue in Multiple Myeloma Therapeutics Business (2017-2022) & (US$ Million)
Table 96. Celgene Corporation Multiple Myeloma Therapeutics SWOT Analysis
Table 97. Celgene Corporation Recent Developments
Table 98. Kesios Therapeutics Limited Company Details
Table 99. Kesios Therapeutics Limited Business Overview
Table 100. Kesios Therapeutics Limited Multiple Myeloma Therapeutics Product and Services
Table 101. Kesios Therapeutics Limited Multiple Myeloma Therapeutics Revenue in Multiple Myeloma Therapeutics Business (2017-2022) & (US$ Million)
Table 102. Kesios Therapeutics Limited Multiple Myeloma Therapeutics SWOT Analysis
Table 103. Kesios Therapeutics Limited Recent Developments
Table 104. Amgene, Inc. Company Details
Table 105. Amgene, Inc. Business Overview
Table 106. Amgene, Inc. Multiple Myeloma Therapeutics Product and Services
Table 107. Amgene, Inc. Multiple Myeloma Therapeutics Revenue in Multiple Myeloma Therapeutics Business (2017-2022) & (US$ Million)
Table 108. Amgene, Inc. Multiple Myeloma Therapeutics SWOT Analysis
Table 109. Amgene, Inc. Recent Developments
Table 110. Genzyme Corporation Company Details
Table 111. Genzyme Corporation Business Overview
Table 112. Genzyme Corporation Multiple Myeloma Therapeutics Product and Services
Table 113. Genzyme Corporation Multiple Myeloma Therapeutics Revenue in Multiple Myeloma Therapeutics Business (2017-2022) & (US$ Million)
Table 114. Genzyme Corporation Multiple Myeloma Therapeutics SWOT Analysis
Table 115. Genzyme Corporation Recent Developments
Table 116. Juno Therapeutics Company Details
Table 117. Juno Therapeutics Business Overview
Table 118. Juno Therapeutics Multiple Myeloma Therapeutics Product and Services
Table 119. Juno Therapeutics Multiple Myeloma Therapeutics Revenue in Multiple Myeloma Therapeutics Business (2017-2022) & (US$ Million)
Table 120. Juno Therapeutics Multiple Myeloma Therapeutics SWOT Analysis
Table 121. Juno Therapeutics Recent Developments
Table 122. Multiple Myeloma Therapeutics Market Trends
Table 123. Multiple Myeloma Therapeutics Market Drivers
Table 124. Multiple Myeloma Therapeutics Market Challenges
Table 125. Multiple Myeloma Therapeutics Market Restraints
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Multiple Myeloma Therapeutics Sales Market Share by Type: 2021 VS 2028
Figure 2. Chemotherapy Features
Figure 3. Radiation Features
Figure 4. Stem Cell Transplant Features
Figure 5. Other Supportive Treatments Features
Figure 6. Global Multiple Myeloma Therapeutics Sales Market Share by Application: 2021 VS 2028
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Multiple Myeloma Therapeutics Report Years Considered
Figure 11. Global Multiple Myeloma Therapeutics Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Multiple Myeloma Therapeutics Market Size 2017-2028 (US$ Million)
Figure 13. Global Multiple Myeloma Therapeutics Market Size Market Share by Region: 2021 VS 2028
Figure 14. Global Multiple Myeloma Therapeutics Revenue Market Share by Region in 2017 VS 2022
Figure 15. Global Top 10 Multiple Myeloma Therapeutics Countries Ranking by Market Size (US$ Million) in 2021
Figure 16. Global Multiple Myeloma Therapeutics Market Share by Players in 2021
Figure 17. Global Top Multiple Myeloma Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multiple Myeloma Therapeutics as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by Multiple Myeloma Therapeutics Revenue in 2021
Figure 19. North America Multiple Myeloma Therapeutics Revenue Market Share by Company in 2021
Figure 20. North America Multiple Myeloma Therapeutics Revenue Market Share by Type (2017-2028)
Figure 21. North America Multiple Myeloma Therapeutics Revenue Market Share by Application (2017-2028)
Figure 22. North America Multiple Myeloma Therapeutics Revenue Share by Country (2017-2028)
Figure 23. U.S. Multiple Myeloma Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 24. Canada Multiple Myeloma Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 25. Europe Multiple Myeloma Therapeutics Revenue Market Share by Company in 2021
Figure 26. Europe Multiple Myeloma Therapeutics Revenue Market Share by Type (2017-2028)
Figure 27. Europe Multiple Myeloma Therapeutics Revenue Market Share by Application (2017-2028)
Figure 28. Europe Multiple Myeloma Therapeutics Revenue Share by Country (2017-2028)
Figure 29. Germany Multiple Myeloma Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 30. France Multiple Myeloma Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 31. U.K. Multiple Myeloma Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 32. Italy Multiple Myeloma Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 33. Russia Multiple Myeloma Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Multiple Myeloma Therapeutics Revenue Market Share by Company in 2021
Figure 35. Asia Pacific Multiple Myeloma Therapeutics Revenue Market Share by Type (2017-2028)
Figure 36. Asia Pacific Multiple Myeloma Therapeutics Revenue Market Share by Application (2017-2028)
Figure 37. Asia Pacific Multiple Myeloma Therapeutics Revenue Share by Region (2017-2028)
Figure 38. China Multiple Myeloma Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 39. Japan Multiple Myeloma Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 40. South Korea Multiple Myeloma Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 41. India Multiple Myeloma Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 42. Australia Multiple Myeloma Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 43. Taiwan Multiple Myeloma Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 44. Indonesia Multiple Myeloma Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 45. Thailand Multiple Myeloma Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 46. Malaysia Multiple Myeloma Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 47. Philippines Multiple Myeloma Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 48. Vietnam Multiple Myeloma Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 49. Latin America Multiple Myeloma Therapeutics Revenue Market Share by Company in 2021
Figure 50. Latin America Multiple Myeloma Therapeutics Revenue Market Share by Type (2017-2028)
Figure 51. Latin America Multiple Myeloma Therapeutics Revenue Market Share by Application (2017-2028)
Figure 52. Latin America Multiple Myeloma Therapeutics Revenue Share by Country (2017-2028)
Figure 53. Mexico Multiple Myeloma Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 54. Brazil Multiple Myeloma Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 55. Argentina Multiple Myeloma Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 56. Middle East and Africa Multiple Myeloma Therapeutics Revenue Market Share by Company in 2021
Figure 57. Middle East and Africa Multiple Myeloma Therapeutics Revenue Market Share by Type (2017-2028)
Figure 58. Middle East and Africa Multiple Myeloma Therapeutics Revenue Market Share by Application (2017-2028)
Figure 59. Middle East and Africa Multiple Myeloma Therapeutics Revenue Share by Country (2017-2028)
Figure 60. Turkey Multiple Myeloma Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 61. Saudi Arabia Multiple Myeloma Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 62. U.A.E Multiple Myeloma Therapeutics Revenue (2017-2028) & (US$ Million)
Figure 63. Janssen Biotech, Inc. Revenue Growth Rate in Multiple Myeloma Therapeutics Business (2017-2022)
Figure 64. Bristol-Myers Squibb Revenue Growth Rate in Multiple Myeloma Therapeutics Business (2017-2022)
Figure 65. Novartis AG Revenue Growth Rate in Multiple Myeloma Therapeutics Business (2017-2022)
Figure 66. Bristol-Myers Squibb Company Revenue Growth Rate in Multiple Myeloma Therapeutics Business (2017-2022)
Figure 67. Millennium Pharmaceuticals Revenue Growth Rate in Multiple Myeloma Therapeutics Business (2017-2022)
Figure 68. Celgene Corporation Revenue Growth Rate in Multiple Myeloma Therapeutics Business (2017-2022)
Figure 69. Kesios Therapeutics Limited Revenue Growth Rate in Multiple Myeloma Therapeutics Business (2017-2022)
Figure 70. Amgene, Inc. Revenue Growth Rate in Multiple Myeloma Therapeutics Business (2017-2022)
Figure 71. Genzyme Corporation Revenue Growth Rate in Multiple Myeloma Therapeutics Business (2017-2022)
Figure 72. Juno Therapeutics Revenue Growth Rate in Multiple Myeloma Therapeutics Business (2017-2022)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed